page full analyst note
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim
price data
rate updat
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
aim customer-centr health compani
unit state spent decad posit
leader healthcar servic acquisit pharmaci
benefit manag caremark insur provid aetna
defin strateg direct top-tier retail pharmaci
health insur pbm franchis creat potenti improv
health outcom even bend healthcar cost curv
success endeavor sharehold could even
benefit double-digit annual earn growth longer
term initi take hold
specif appear uniqu posit improv health
outcom retail network nearli store
top-tier posit manag medic pharmaci benefit
move step beyond establish minuteclin offer
aim introduc healthhub concept store
end potenti thereaft care
concierg nurs practition dietitian addit
pharmacist alreadi staff store aim provid
conveni way peopl check health condit
current minuteclin visitor primari
care physician even fewer visit doctor annual
provid quick way check basic health factor person
alreadi store compani aim identifi gap
care introduc therapi prevent patient need
intens like costli intervent acut
new format return potenti improv
servic line retail store instanc
recent acquir insur asset benefit insur
patient control chronic condit pharmaceut rather
requir major surgeri intens therapi like dialysi
pharmaceut volum could rise benefit
pharmaci pbm asset societi could also benefit patient
remain healthier earlier intervent creat lower
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
follow acquisit aetna late provid
even integr healthcare-servic offer member
legaci combin largest pharmaci benefit manag
process billion adjust claim annual sizabl pharmaci
oper includ nearli retail pharmaci locat primarili
 ad managed-car organ million medic
member give compani strong posit insur industri
help better control overal healthcar cost client
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
taken fresh look health insur
continu view stock
under-valued howev review competit
dynam on-going debat player long-
term role health system reduc moat
rate narrow wide cut
moat trend rate stabl posit
compani narrow moat stabl
 health system continu put signific financi
pressur mani citizen think medic
insur pharmaci benefit manag remain key
target regul look improv healthcar
system organ may continu face
signific event risk could cut profit
eventu manag chang current statu
quo appear much like extrem chang like
drastic medicar scenario elimin privat
insur intermedi term potenti on-going
pressur profit strain healthcar system
act fundament constraint moat moat trend
rate industri
specif longer feel confid enough endors
wide moat rate impli excess return least
next year despit unriv
scale advantag health insur industri
similarli longer view potenti synergi
associ combin retail pbm
aetna insur combin
insur express script pbm compel enough
off-set underli constraint industri player
addit return
valuat paid merger therefor cut
moat trend rate stabl posit
valuat perspect three player continu
trade fair valu estim though believ
market place much weight extrem
medicar scenario elimin privat insur
admittedli pure medicar scenario
insur place insur market
compani medic pharmaci benefit
manag oper could jeopardi
busi repres oper profit
two third oper profit
oper profit howev
believ scenario repres low-prob
less risk within forecast period would
requir signific shift control current feder
major posit senat new presid
far-left wing democrat parti
view scenario organ provid
medic pharmaceut benefit employ
even govern entiti medicar advantag
medicaid managed-car plan much like
extrem medicar scenario privat
insur industri longer exist like
scenario suspect place privat health
insur relat pharmaci benefit manag
healthcar system rel long period
like scenario give us confid base-
case valuat scenario recent trade
similar discount fair valu estim
share offer time expect
earn expect compound annual growth
earn next five year includ
acceler high singl digit outer year
period roughli flat result stock
recent trade time expect earn
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
retail forecast revenu growth compound
annual next five year expect
store count growth increas driven
rise revenu per store new healthhub
new store format add potenti growth continu
expect stronger growth pharmaci oper
midsingl digit versu front store low singl
digit howev pharmaci oper look like
neg affect continu declin revenu per
prescript process pbm continu exert pressur
pharmaci network includ store
trim expect pbm recent
client loss current expect minim revenu
growth busi next five year
specif expect claim growth
somewhat off-set price pressur primarili mail
order busi new competitor could enter fray
amazon pharmaci network channel expect
larg neutral revenu per claim larg client loss lead
mild revenu mix benefit off-set on-going
final aetna expect posit sale environ
medic pharmaci benefit combin specif
project pro forma sale growth compound
annual includ membership growth around
next five year particular strength govern
discount assumpt weight averag
cost capit around
deriv synergi aetna acquisit
on-going debat around healthcar system
runup elect
compound annual earn growth expect us
next five year recent trade
discount fair valu estim time
expect earn expect increas
earn per share compound annual
next five year
fair valu estim remain per share
impli time multipl expect earn
next five year expect pro forma top
line adjust earn per share grow
respect compound annual basi investor
note aim acceler bottom-lin
growth low doubl digit variou
cost-sav program lower interest expens debt
repay share repurchas synergi
acceler earn growth period
high singl digit includ margin expans
also expect mid- high-single-digit earn
growth outer year forecast includ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
bull-cas scenario valu per share
time expect earn scenario
assum revenu grow annual next five
year basi point base-cas
scenario includ higher growth firm
control addit synergi combin
oper oper margin rise basi point
base case bull case adjust
earn per share grow compound annual
next five year basi point
base case
bear-cas scenario valu per share
time earn scenario assum pro
forma growth top line next five year
dip next year assum firm
oper margin return level
share repurchas benefit adjust earn
per share grow compound annual
next five year scenario like scenario
though scenario also incorpor earn growth
acceler outer year forecast
view like even dire
scenario bear case possibl exampl
extrem medicar scenario could elimin
insur pharmaci benefit manag oper
compani oper profit
scenario investor know
enterpris valu base scenario relat valu
firm cash flow explicit
earn narrow econom moat rate us
benefit manag insur believ possess
gener
econom profit long run even late
aetna merger cut return invest capit
includ goodwil somewhat estim roic
remain capit cost throughout explicit
view inform analysi potenti chang
 healthcar system despit medicar
scenario debat part elect
cycl admittedli medicar scenario
insur place market medic
pbm oper repres firm
oper profit could jeopardi believ
scenario repres very-low-prob less risk
within forecast period would requir
signific shift control feder govern
includ filibuster-proof democrat major
senat new presid far left wing
democrat parti view scenario provid
medic pharmaceut benefit employ
even govern entiti medicar
medicaid-rel plan much like
extrem medicar scenario privat
insur industri longer exist like
scenario suspect place privat health
insur relat pharmaci benefit manag
healthcar system rel long period
scenario cost advantag present
organ network effect also support
insur oper profit switch
cost support pbm busi profit
retail oper establish signific scale
enabl leverag negoti power
supplier differenti abil gener
signific volum nearli pharmaci
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
locat includ store larg store
network attract pharmaci benefit manag
assembl plan obtain volume-bas discount
pharmaceut manufactur also assembl
conveni retail store locat would attract
insur plan member firm dispens
billion adjust prescript even
billion dispens walgreen trail
million averag store revenu still
significantli higher pharmaci averag
million scale allow leverag fix cost
pharmacist salari rent effect subscal
peer contribut improv market share
like walgreen versu declin market
share smaller independ pharmaci deterior
third largest competitor
caremark segment provid pbm servic appear
competit advantag right cost
advantag switch cost pbm industri
consolid three top playerscv
cignacontrol roughli prescript
volum adjust basi believ leadership
posit pbm oper help gener
excess return time continu view fixed-cost
leverag associ process billion
nearli billion adjust prescript fill annual
 scale-rel advantag addit
consolid purchas power help extract
discount drug manufactur one end
transact pharmaci end
transact help creat valu client
insur plan employ pharmaci cost
trend addit cost-rel advantag see
switch cost busi contract
length typic around three year annual retent
rate high three top-tier pbm player
switch administr activ partner relationship
pharmaci benefit plan specif new pbm
vendor time-consum oner creat
inertia client limit realist altern
opinion howev switch possibl
season sell includ loss
client constrain pbm growth least
near term
insur see two moat sourcescost advantag
network effect insur cost advantag relat
primarili scale broadli local aetna
repres fifth-largest insur nation measur
premium written like third fourth
sizabl fee-bas
largest membership given
enrol mix signific scale
fragment health insur market believ
benefit broad cost advantag abl
leverag fix central cost increas
profit potenti margin life cover
organ compar smaller peer also
benefit scale advantag specif locat
exampl compani posit either first-
second-largest insur term premium written two
state district columbia may seem
small compar number one two
state number one two nine state
beat top-tier competitor
metric fragment industri
believ influenc like even stronger look
specif metropolitan area local scale advantag allow
greater negoti leverag versu servic provid
smaller insur commun contribut
cost advantag
also local scale advantag signific enough
think insur oper benefit network
effect exampl commun alreadi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
effect treat chronic condit beyond
potenti effici improv store
activ could eventu improv return
segment help boost fill prescript volum
potenti benefit pbm prevent costli medic
procedur potenti benefit insur oper
one could even argu coordin care oper
like could help bend healthcar cost curv
 aim one organ lead
charg effort would like attract
client servic offer
howev health system also continu put
signific financi pressur mani citizen
think medic insur pharmaci benefit manag
remain key target regul look improv
healthcar system organ may continu
face signific event risk could cut profit
eventu manag chang current statu
quo appear much like extrem potenti
chang like medicar scenario elimin
privat insur industri potenti on-going
pressur profit strain healthcar system
act fundament constraint moat trend
substanti market share offer lower cost
benefit per member exist potenti client
peer offer compel enough
employ attract insur plan
commun local servic provid hospit
physician group incent join
offer lower price insur network gain access
larg grow membership roll local market
share rise negoti leverag provid also
rise creat virtuou cycl attract
even client provid insur
network area overal dynam creat barrier
entri would-b competitor compil
attract price provid network new geographi
would difficult without establish membership pool
view moat trend stabl consid
capit invest acquir aetna insur asset
return next five year appear unlik improv
substanti premerg level see mani
potenti synergi combin busi
believ abil gener excess return
improv substanti intermedi term
keep moat trend stabl
continu monitor firm cross-sel
opportun way eventu improv advantag
though offer combin medic pharmaci benefit
plan abl help client manag overal
healthcar cost better offer holist view
care option also remain intrigu strategi
offer healthcar servic network retail
store move step beyond establish minuteclin
offer aim introduc extens
healthhub concept store end
potenti thereaft format
aim provid conveni way peopl check
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
ocv combin aetna creat opportun
view patient holist manag
medic pharmaci benefit could lead
revenu cost synergi organ
ohealthcar reform like recur topic
throughout upcom elect cycl
could constrain stock especi high-risk
oth healthhub concept potenti improv
return servic line help
patient easili cost-effect manag
chronic condit earli intervent
oth bulk insur membership growth
come year like stem lower-margin
headwind insur profit
ocv ownership largest nation pbm provid
substanti negoti
leverag cost
advantag claim process allow best-
ofoot traffic physic retail store could continu
declin consum behavior increasingli favor
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
financi posit remain manag
take billion increment debt acquir
aetna investor watch manag capit
prioriti close transact close late
firm pro forma leverag ratio stood around time
manag outlin de-lever path
believ achiev compani shoot gross
leverag low reach goal
manag aim use excess free cash flow
repay debt interim period plan refrain
share repurchas maintain current dividend
reach leverag goal though anticip
return regular dividend growth buy-back activ
manag said expect billion
billion avail cash flow annual deploy
benefit sharehold reach leverag target
also would surpris see make
acquisit well given histori transform
acquisit similarli larg acquisit adjac field
possibl reach reason leverag
deriv synergi aetna acquisit
on-going debat around healthcar system
runup elect aetna merger creat
integr execut financi risk combin
two larg organ multi-year process
may go perfectli smooth synergi
anticip
organ may never
materi addit took substanti debt
merg aetna creat anoth set financi
risk top oper risk stock may
constrain elect cycl health
insur like aetna pbm like caremark face signific
regulatori threat dire scenario would
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
medicar scenario elimin privat
insur industri aetna medic pharmaci
oper could eventu phase one-pay
system view scenario probabl
low point creat signific event risk
organ even far-left democrat win white
hous view chang margin like
especi democrat reach filibuster-proof
major senat moder potenti
chang includ modif afford
act continu expans medicaid earli
buy-in option medicar insur like play
key role moder scenario could even
benefit expans servic uncertainti may
surround stock clariti potenti
regulatori chang beyond uncertainti retail
industri remain threat on-line retail
amazon consum continu forgo shop
physic store conveni at-hom shop
front-of-stor
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
repres date owner name posit common share held report holder issuer
share
fund
share
fund
recent acquisit histori repres
signific constraint score think
compani move made sens strateg price
debt requir make aggress
opinion exampl impair billion
goodwil relat billion omnicar long-term
care acquisit complet
write-down repres nearli goodwil relat
deal suggest significantli overpaid
asset also paid doubl thought
aetna worth prior acquisit announc
late see signific potenti synergi
combin organ return
invest capit weaken merger
continu worri paid much especi light
on-going debat insur industri
 healthcar system addit taken
substanti financi leverag acquir aetna credit
rate cut compani capit alloc
activ probabl sever limit next
year exampl forgo share repurchas
share appear cheap opinion intend
maintain dividend reach gross leverag
target low around acquisition-rel
factor constrain view compani stewardship
asid acquisition-rel concern think
ceo larri merlo done fine job lead oper
sinc pharmacist train merlo
involv sinc instrument
transit true healthcare-focus organ
given size scope aetna acquisit though
think success failur deal like defin
merlo tenur ceo importantli mani key aetna leader
remain organ follow
transact includ karen lynch lead
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
busi unit former aetna ceo mark bertolini
remain board
addit strong leadership team enterpris
think board put place solid compens
program align incent manag
sharehold bulk merlo compens driven
equiti incentive-bas award comprehens
set goal think consist build
intrins valu firm annual cash bonus tie
primarili firm-wide oper profit along custom
satisfact measur pbm retail segment
perform stock unit long-term natur
current focus aetna-rel synergi rel
total sharehold return addit board recent
introduc perform stock unit vest three
year tie ebitda target compani
issu option execut incent well
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
taken fresh look health insur
continu view stock
under-valued howev review competit
dynam on-going debat player long-
term role health system reduc moat
rate narrow wide cut
moat trend rate stabl posit
compani narrow moat stabl
 health system continu put signific financi
pressur mani citizen think medic
insur pharmaci benefit manag remain key
target regul look improv healthcar
system organ may continu face
signific event risk could cut profit
eventu manag chang current statu
quo appear much like extrem chang like
drastic medicar scenario elimin privat
insur intermedi term potenti on-going
pressur profit strain healthcar system
act fundament constraint moat moat trend
rate industri
specif longer feel confid enough endors
wide moat rate impli excess return least
next year despit unriv
scale advantag health insur industri
similarli longer view potenti synergi
associ combin retail pbm
aetna insur combin
insur express script pbm compel enough
off-set underli constraint industri player
addit return
valuat paid merger therefor cut
moat trend rate stabl posit
valuat perspect three player continu
trade fair valu estim though believ
market place much weight extrem
medicar scenario elimin privat insur
admittedli pure medicar scenario
insur place insur market
compani medic pharmaci benefit
manag oper could jeopardi
busi repres oper profit
two third oper profit
oper profit howev
believ scenario repres low-prob
less risk within forecast period would
requir signific shift control current feder
major posit senat new presid
far-left wing democrat parti
view scenario organ provid
medic pharmaceut benefit employ
even govern entiti medicar advantag
medicaid managed-car plan much like
extrem medicar scenario privat
insur industri longer exist like
scenario suspect place privat health
insur relat pharmaci benefit manag
healthcar system rel long period
like scenario give us confid base-
case valuat scenario recent trade
similar discount fair valu estim
share offer time expect
earn expect compound annual growth
earn next five year includ
acceler high singl digit outer year
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
period roughli flat result stock
recent trade time expect earn
compound annual earn growth expect us
next five year recent trade
discount fair valu estim time
expect earn expect increas
earn per share compound annual
next five year
turn strong third quarter boost
narrow-moat turn third-quart oper
result beat capit iq consensu top bottom
line strong trend manag rais
metric outlook slightli although cash flow
guidanc chang overal continu view
share under-valued see compel cross-sel
opportun synergi organ
integr aetna insur oper legaci
retail store pharmaci benefit manag busi
quarter revenu reach billion
consensu billion adjust earn per share
grew consensu
relat capit gain posit prior-
year develop compani underli busi
perform well manag rais adjust ep
guidanc howev
guidanc oper cash flow
billion capit expenditur billion
primari driver fair valu estim
chang
growth claim process million quarter
adjust basi adjust oper incom grew
billion due on-going price compress
retail/long-term care segment grew year year
billion sale adjust oper incom
declin billion quarter due primarili
reimburs pressur posit though retail store
oper remain strong increas
prescript volum increas
prescript share unit state
legaci aetna oper compani gener billion
sale adjust oper incom billion
manag highlight beat intern expect
integr oper model appear creat
initi benefit year sinc aetna
acquisit close notabl sinc second-quart call
manag increas outlook pbm
billion sell season client win
appear relat new integr model also
earli sign healthhub expans suggest
store benefit higher prescript volum higher
front-of-stor sale higher store margin compani
expect open healthhub end
end current could see
addit benefit open futur period
outlook manag includ risk
valuat attract across board aug
took detail look managed-car industri
came away confid posit outlook space
manag care remain attract industri
allow format sizabl econom moat
protect strong return capit almost everi corner
sector compani built advantag busi
model around monthli premium fee gener
recur revenu consolid past decad
allow competit remain ration despit
attract qualiti group trade modest discount
broader market reflect investor concern
futur healthcar polici regul unit
headlin domin variou democrat
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
parti polici propos medicar
would overhaul healthcar industri addit
manag care wrestl propos regulatori action
put forward trump administr so-
call rebat rule think medicar
function similar polici unlik next decad
administr abandon rebat rule earlier
year mark win industri valuat space
compress result heighten concern
market particip regard action think
investor long-term invest horizon stand
benefit own moatworthi firm favor
price integr servic offer unitedhealth
group make favorit among
five firm cover current trade discount
dcf-deriv fair valu estim
uncertainti like persist
gener elect cycl think group averag
valuat level roughli time earn emb
sizable-enough margin safeti warrant posit
detail analysi industri
assess potenti polici implic pleas see
risk manag creat opportun
moatworthi firm sizabl discount
bull case remain intact result
report second string strong quarter
follow acquisit aetna late updat
model contempl better-than-expect perform
to-dat manag modestli higher ep outlook
year forese substanti
chang per share fair valu estim
narrow-moat name remain territori current
trade near time higher earn outlook -- share
remain attract opportun view
saw last quarter retail pharmaci segment
continu post better-than-anticip growth led
same-stor script volum expand firm
expand particip pharmaci benefit manag
narrow network offer help acceler script
growth last year half notabl front store
sale also acceler nice nearli same-
store basi adjust calendar varianc versu last
year help somewhat extend flu season
pbm script growth line
expect although segment margin held much
better origin expect per-script profit
expand modestli year date despit initi
onboard volum -- assum mid-
single-digit declin year
manag care franchis continu perform well
overal medic enrol continu grow modestli
first quarter segment geograph
expans medicar advantag marketplac
continu propel membership higher
busi post medic loss ratio quarter
consist expect although
year-to-d figur help modest favor
reserv develop overal full-year result track
modestli ahead initi estim well within
manag initi outlook call
view compani earli post-merg result
continu underscor posit moat trend rate
combin entiti integr aetna add cost
advantag underpin narrow econom moat
profit busi segment outpac
expect help realiz synergi led
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
cost insur plan overal led ralli
pbms/insur distributor drug stock sank
investor wonder presid donald trump focu
turn next take rebat reform tabl put
pressur congress particularli bipartisan senat
financ committe team chuck grassley ron wyden
reveal drug-pric packag month stand
chanc pass chamber potenti reform
like reduc cost medicar patient also look
modest payer drug firm
think remain propos review
budget offic -- medicar part intern price
index -- unlik implement even final
congress power block rule judici review
could find massiv demonstr overextens
author center medicar medicaid
innov cmmi
altern expect senat drug price packag
could includ part reform also includ cap
out-of-pocket spend medicar part anticip
propos would see widespread support
policymak result higher likelihood
success think chang would manag
drug firm effect achiev bipartisan
polici goal lower healthcar cost american
addit detail analysi effect
rebat rule elimin pleas see report rebat
earn beat roughli compar
estim manag revis ep outlook full
year impli higher-than-anticip third quarter
lower project fourth quarter given season
pattern busi overal approxim
midpoint year look somewhat conserv rel
result thu far surpris see
addit upsid come month
last quarter highlight weaken retent rate
pbm on-going sell season
potenti caus concern time howev
pleas see manag report billion
improv net new busi compar figur
report june analyst day help grow
new win improv client retent last two
final outlook pbm industri larg
somewhat de-risk administr juli decis
abandon depart human servic
propos polici chang drug rebat practic pleas
see report rebat rule dead suppli chain benefit
drug firm pressur in-depth review
industry-specif effect unexpect shift
first report juli axio trump administr
plan final propos rule alter flow
drug rebat purchas medicar part plan
rule would chang busi model
pharmaci benefit manag requir negoti
discount pass directli beneficiari
point sale rather use mechan lower
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
